Portfolio Update - 12/31/08


By Matt McCracken - Posted on 03 January 2009

By proceeding, I acknowledge that I have read and understood the Disclaimer, Performance Reporting Disclosure and Copyright Statements . Dear clients, We finished off the year strong yet I was unable to get your accounts into the black for 2008. Our losses were far less than the great majority of investors, yet I am disappointed in having experienced any losses at all. Here is how my performance has stacked up compared to the averages:

PORTFOLIO Q4 2008 2 Yr Trailing1 3 Yr Trailing1
MAC’s Core Portfolio 7.6% (8.0%) 3.5% 11.5%
MAC’s Focus Port. (IRA Accts) 2 7.5% (7.3%) 2.9% N/A
MAC’s Focus Port (Margin)2 17.4% 58.2% 82.0% N/A
S&P 500 (VFINX) (22.6%) (37.6%) (34.2%) (23.9%)
NASDAQ 100 (QQQQ) (23.5%) (41.7%) (30.6%) (25.7%)
Benchmark (13.3%) (20.0%) (13.1%) (6.2%)
  1. Trailing 2 and 3 year returns are cumulative total returns and not average annual returns. The figures represent the cumulative average returns for all participants in each respective strategy.
  2. We implement our Focus Portfolio inside of IRA accounts and margin accounts. In margin accounts, we are able to short sell individual securities providing us with greater opportunities to profit when stocks prices decline. The risk with short selling securities is substantial as it can result in losing more than a 100% of your initial investment. The performance dispersion of our margin accounts is greater than in our IRA accounts due to margin requirements, tax-loss selling and ability to borrow shares to sell short.

Despite the losses this year in our primary strategies, we are blessed to have experienced gains over the past 2 – 3 years. Few investors can claim this feat. I am hopeful for the future based on my performance in the past quarter since I implemented my new trading measures. I will provide an in-depth explanation in my annual report. I hope to mail it to you by Wednesday, January 7th. All the best, Matt

6ItTju order accutane ytz cialis ehlia cialis 373 valium no prescription 2834 valium :-OOO

Contact

To discuss your portfolio, please fill out the form below.

WEBSITE DISCLAIMER and COPYRIGHT STATEMENT

McCracken & Company (MAC) is a registered as an Investment Adviser with the State of Texas Securities Board. Our firm's registration with the State of Texas Securities Board is not an endorsement for the firm. The information on this world wide website is for general information purposes only. The MAC is not liable for any decision based on the information of this website. All content expressed herein constitute the judgment of the staff of the MAC. The information contained on this website is from sources that we believe to be reliable however we do not guarantee its accuracy or completeness.

The works of authorship contained in this website in the domain www.investorsadv.com, including but not limited to all design, text, images, charts or other data are owned by McCracken & Company and may not be copied, reproduced, transmitted, displayed, distributed, altered, stored or sublicensed for subsequent use in whole or in part in any manner without written permission from McCracken & Company.